Alicia Harbin

710 citations
2 papers · 400 indexed · 1 hit paper · h-index 2
Topics
Ubiquitin and proteasome pathways (2 papers)Protein Degradation and Inhibitors (2 papers)Multiple Myeloma Research and Treatments (1 paper)
Partner nations
United States

In The Last Decade

Alicia Harbin

2 papers receiving 385 citations

Hit Papers

Differential PROTAC substrate specificity dictated by ori...20192026202120232019100200300

Peers

Alicia Harbin
Comparison fields: 5 of 36
  • Molecular Biology 392
  • Oncology 185
  • Hematology 100
  • Cell Biology 15
  • Organic Chemistry 10
Replace Inchul You with:
Inchul You United States
Aleksas Matvekas United States
Xing Qiu China
Cyrille S. Kounde United Kingdom
Stephen L. DeAngelo United States
Tomoko Asatsuma‐Okumura Japan
Corinna Wieshofer Austria
Hoda Metwally United States
Sarah D. Mahan United States
Conner Craigon United Kingdom
Alicia Harbin relative to Inchul You United States Inchul You's profile →
Citations per field
00.5×5.9×
Inchul You · 1×
Citations per year

Countries citing papers authored by Alicia Harbin

Since Specialization
Citations

This map shows the geographic impact of Alicia Harbin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alicia Harbin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alicia Harbin more than expected).

Fields of papers citing papers by Alicia Harbin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alicia Harbin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alicia Harbin. The network helps show where Alicia Harbin may publish in the future.

Co-authorship network of co-authors of Alicia Harbin

This figure shows the co-authorship network connecting the top 25 collaborators of Alicia Harbin. A scholar is included among the top collaborators of Alicia Harbin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alicia Harbin. Alicia Harbin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

2 of 2 papers shown
#WorkIndexed citations
1 29
2
Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligasebreakdown →
371

About Alicia Harbin

Alicia Harbin is a scholar working on Hematology, Oncology and Molecular Biology, having authored 2 papers that have together received 400 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (2 papers), Protein Degradation and Inhibitors (2 papers) and Multiple Myeloma Research and Treatments (1 paper). The work is most often cited by research in Hematology (100 citations), Oncology (185 citations) and Molecular Biology (392 citations). Alicia Harbin has collaborated with scholars based in United States. Frequent co-authors include Brian D. Hamman, Stephen L. Wang, Blake E. Smith, Craig M. Crews, Saul Jaime‐Figueroa, Jing Wang, Katherine M. Digianantonio, John Corradi, Christopher M. Hickey and Angela Cacace. Their work appears in journals such as Nature Communications and Nature Structural & Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026